Last edition
News about "Tourette syndrome treatment"
Teva Completes Acquisition of Emalex Biosciences
Teva has completed its acquisition of Emalex Biosciences, strengthening its late-stage neuroscience pipeline. The deal supports Teva’s Pivot to Growth strategy.
Tourette Syndrome Treatment | 12/06/2026 | By News Bureau
Emalex Secures US Patent for Ecopipam ODT
Emalex secures a US composition-of-matter patent for its orally disintegrating ecopipam formulation, advancing drug development and expanding patient access.
Tourette Syndrome Treatment | 10/04/2026 | By News Bureau | 201
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy